Skip to main content
SpringerLink
Log in

The UK NICE is recommending rituximab for use on the NHS in England and Wales

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. PharmaTimes.NICE looks favourably on Roche's MabThera for leukaemia. Pharma Times: [2 pages], 16 Jun 2009. Available from: URL: http://www.pharmatimes.com

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

The UK NICE is recommending rituximab for use on the NHS in England and Wales. Pharmacoecon. Outcomes News 581, 11 (2009). https://doi.org/10.2165/00151234-200905810-00037

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905810-00037

Keywords

Search

Navigation